Article (Scientific journals)
Republished: Value of biomarkers in osteoarthritis: current status and perspectives.
Lotz, M.; Martel-Pelletier, J.; Christiansen, C. et al.
2014In Postgraduate Medical Journal, 90 (1061), p. 171-8
Peer Reviewed verified by ORBi
 

Files


Full Text
Value of biomarkers in osteoarthritis current status and perspectives.pdf
Publisher postprint (3.68 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Inflammation; Osteoarthritis; Outcomes research
Abstract :
[en] Osteoarthritis affects the whole joint structure with progressive changes in cartilage, menisci, ligaments and subchondral bone, and synovial inflammation. Biomarkers are being developed to quantify joint remodelling and disease progression. This article was prepared following a working meeting of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis convened to discuss the value of biochemical markers of matrix metabolism in drug development in osteoarthritis. The best candidates are generally molecules or molecular fragments present in cartilage, bone or synovium and may be specific to one type of joint tissue or common to them all. Many currently investigated biomarkers are associated with collagen metabolism in cartilage or bone, or aggrecan metabolism in cartilage. Other biomarkers are related to non-collagenous proteins, inflammation and/or fibrosis. Biomarkers in osteoarthritis can be categorised using the burden of disease, investigative, prognostic, efficacy of intervention, diagnostic and safety classification. There are a number of promising candidates, notably urinary C-terminal telopeptide of collagen type II and serum cartilage oligomeric protein, although none is sufficiently discriminating to differentiate between individual patients and controls (diagnostic) or between patients with different disease severities (burden of disease), predict prognosis in individuals with or without osteoarthritis (prognostic) or perform so consistently that it could function as a surrogate outcome in clinical trials (efficacy of intervention). Future avenues for research include exploration of underlying mechanisms of disease and development of new biomarkers; technological development; the 'omics' (genomics, metabolomics, proteomics and lipidomics); design of aggregate scores combining a panel of biomarkers and/or imaging markers into single diagnostic algorithms; and investigation into the relationship between biomarkers and prognosis.
Disciplines :
General & internal medicine
Author, co-author :
Lotz, M.
Martel-Pelletier, J.
Christiansen, C.
Brandi, M.-L.
Bruyère, Olivier  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Chapurlat, R.
Collette, Julien ;  Université de Liège - ULiège
Cooper, C.
Giacovelli, G.
Kanis, J. A.
Karsdal, M. A.
Kraus, V.
Lems, W. F.
Meulenbelt, I.
Pelletier, J.-P.
Raynauld, J.-P.
Reiter-Niesert, S.
Rizzoli, R.
Sandell, L. J.
Van Spil, W. E.
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
More authors (11 more) Less
Language :
English
Title :
Republished: Value of biomarkers in osteoarthritis: current status and perspectives.
Publication date :
2014
Journal title :
Postgraduate Medical Journal
ISSN :
0032-5473
eISSN :
1469-0756
Publisher :
BMJ Publishing Group, United Kingdom
Volume :
90
Issue :
1061
Pages :
171-8
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 20 February 2014

Statistics


Number of views
61 (16 by ULiège)
Number of downloads
9 (9 by ULiège)

Bibliography


Similar publications



Contact ORBi